Engineered bacteriophages for treatment of a patient with a disseminated drug resistant Mycobacterium abscessus

MLA

Carlos A Guerrero-Bustamante, et al. “Engineered Bacteriophages for Treatment of a Patient with a Disseminated Drug Resistant Mycobacterium Abscessus.” Nature Medicine, vol. 25, no. 5, May 2019, pp. 730–33. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c3a3e22444c07b65536e3d8631a3865c&authtype=sso&custid=ns315887.

APA

Carlos A Guerrero-Bustamante, Katrina Ford, James Soothill, Kimberly Gilmour, Kathryn A. Harris, Daniel A. Russell, Rebekah M. Dedrick, Deborah Jacobs-Sera, Helen Spencer, Robert T. Schooley, Rebecca A. Garlena, & Graham F. Hatfull. (2019). Engineered bacteriophages for treatment of a patient with a disseminated drug resistant Mycobacterium abscessus. Nature Medicine, 25(5), 730–733.

Chicago

Carlos A Guerrero-Bustamante, Katrina Ford, James Soothill, Kimberly Gilmour, Kathryn A. Harris, Daniel A. Russell, Rebekah M. Dedrick, et al. 2019. “Engineered Bacteriophages for Treatment of a Patient with a Disseminated Drug Resistant Mycobacterium Abscessus.” Nature Medicine 25 (5): 730–33. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c3a3e22444c07b65536e3d8631a3865c&authtype=sso&custid=ns315887.